A study in the October 2009 Gastroenterology compares colectomy rates following treatment of ulcerative colitis with placebo or infliximab. Dr. Kuemmerle speaks with the senior author, Dr. William Sandborn of the Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota.